- Patient/Guest
- Phlebotomist
- Updates
| Oxalate Urine | - |
|---|
|
Measure oxalate in urine |
||
| Synonym | See updates | |
| Test Code | CDBIOPR0033 | |
| Test Type | Biochemistry | |
| Pre-Test Condition | See updates | |
| Report Availability | 3 D(s) | |
| # Test(s) | 1 | |
| Test details | Sample Report |
|---|---|
| Oxalate Urine |
|
| Synonym | See updates | ||
| Test Code | CDBIOPR0033 | ||
| Test Category | Kidney stones | ||
| Pre-Test Condition | See updates | ||
| |
Medical History | See updates | |
| Report Availability | 3 D(s) | ||
| Specimen/Sample | Urine; 24 hr; Preserv Cont | ||
| Stability @21-26 deg. C | 6 Hr(s) | ||
| Stability @ 2-8 deg. C | 7 D(s) | ||
| Stability @ Frozen | NA | ||
| # Test(s) | 1 | ||
| Processing Method | Spectrophotometry | ||
| **Oxalate 24 Hrs Urine****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: 24-Hour Urine Oxalate Test, Kidney Stone Risk Test.**Historical Breakthrough**: Developed in the 1970s to assess kidney stone risk, advancing nephrology.**Key Purpose and Impact**: Measures oxalate in 24-hour urine to diagnose hyperoxaluria or kidney stone risk.**Preparation and Patient History**: 24-hour urine; report kidney stones, abdominal pain, or dietary history.**Consent Requirement**: Standard consent for non-invasive sample collection.**Clinical Value**: Sensitivity ~90%; specificity ~95%; detects abnormalities in ~70% of cases; guides therapy.**References Cited**: Testing.com Kidney Tests 2023; Labcorp Oxalate Test 2025; UpToDate Kidney Stones 2025 |
